Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Tuberculosis D014376 20 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Insulinoma D007340 28 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Sarcoma 180 D012510 21 associated lipids
Edema D004487 152 associated lipids
Arthritis D001168 41 associated lipids
Heart Failure D006333 36 associated lipids
Pulmonary Edema D011654 23 associated lipids
Coronary Disease D003327 70 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Hypersensitivity D006967 22 associated lipids
Acne Vulgaris D000152 35 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Melanoma D008545 69 associated lipids
Anemia, Aplastic D000741 6 associated lipids
Asthma D001249 52 associated lipids
Weight Gain D015430 101 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Liver Neoplasms, Experimental D008114 46 associated lipids
Proteinuria D011507 30 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Arteriosclerosis D001161 86 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Fibrosis D005355 23 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Psoriasis D011565 47 associated lipids
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Nerve Degeneration D009410 53 associated lipids
Hypertension D006973 115 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Thrombocythemia, Essential D013920 9 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Hyperalgesia D006930 42 associated lipids
Anaphylaxis D000707 35 associated lipids
Thrombocytopenia D013921 15 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Rhabdomyosarcoma D012208 7 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Cardiomyopathies D009202 10 associated lipids
Shock, Hemorrhagic D012771 4 associated lipids
Adenoma D000236 40 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Vascular Diseases D014652 16 associated lipids
Ovarian Diseases D010049 5 associated lipids
Anemia D000740 21 associated lipids
Glioblastoma D005909 27 associated lipids
Fabry Disease D000795 4 associated lipids
Influenza, Human D007251 11 associated lipids
Retinal Detachment D012163 10 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Atherosclerosis D050197 85 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Insulin Resistance D007333 99 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Endotoxemia D019446 27 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Acute Lung Injury D055371 33 associated lipids
Sensation Disorders D012678 2 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Hematologic Neoplasms D019337 4 associated lipids
Neuralgia D009437 28 associated lipids
Muscular Dystrophy, Duchenne D020388 11 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Lung Injury D055370 14 associated lipids
Teratocarcinoma D018243 7 associated lipids
Eye Abnormalities D005124 7 associated lipids
Pregnancy, Ectopic D011271 5 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Ileus D045823 3 associated lipids
Tachycardia, Sinus D013616 2 associated lipids
Adenomatous Polyps D018256 4 associated lipids
Niemann-Pick Disease, Type C D052556 1 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Kulinski JM et al. Sphingosine-1-phosphate and other lipid mediators generated by mast cells as critical players in allergy and mast cell function. 2016 Eur. J. Pharmacol. pmid:25941085
Al Fadel F et al. Involvement of Sphingosine 1-Phosphate in Palmitate-Induced Non-Alcoholic Fatty Liver Disease. 2016 Cell. Physiol. Biochem. pmid:28006772
Bigaud M et al. Pathophysiological Consequences of a Break in S1P1-Dependent Homeostasis of Vascular Permeability Revealed by S1P1 Competitive Antagonism. 2016 PLoS ONE pmid:28005953
Gharbaran R Insights into the molecular roles of heparan sulfate proteoglycans (HSPGs-syndecans) in autocrine and paracrine growth factor signaling in the pathogenesis of Hodgkin's lymphoma. 2016 Tumour Biol. pmid:27317256
Higashi K et al. Sphingosine-1-phosphate/S1PR2-mediated signaling triggers Smad1/5/8 phosphorylation and thereby induces Runx2 expression in osteoblasts. 2016 Bone pmid:27612439
Sasset L et al. Sphingolipid De Novo Biosynthesis: A Rheostat of Cardiovascular Homeostasis. 2016 Trends Endocrinol. Metab. pmid:27562337
Roviezzo F et al. Disodium cromoglycate inhibits asthma-like features induced by sphingosine-1-phosphate. 2016 Pharmacol. Res. pmid:27713021
Hemdan NY et al. Modulating sphingosine 1-phosphate signaling with DOP or FTY720 alleviates vascular and immune defects in mouse sepsis. 2016 Eur. J. Immunol. pmid:27683081
Custódio R et al. Characterization of secreted sphingosine-1-phosphate lyases required for virulence and intracellular survival of Burkholderia pseudomallei. 2016 Mol. Microbiol. pmid:27632710
Ebenezer DL et al. Targeting sphingosine-1-phosphate signaling in lung diseases. 2016 Pharmacol. Ther. pmid:27621206
Tsuchida J et al. Breast cancer sphingosine-1-phosphate is associated with phospho-sphingosine kinase 1 and lymphatic metastasis. 2016 J. Surg. Res. pmid:27621003
Harijith A et al. Hyperoxia-induced p47phox activation and ROS generation is mediated through S1P transporter Spns2, and S1P/S1P1&2 signaling axis in lung endothelium. 2016 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:27343196
Hernández-Coronado CG et al. Sphingosine-1-phosphate, regulated by FSH and VEGF, stimulates granulosa cell proliferation. 2016 Gen. Comp. Endocrinol. pmid:27342378
Chakrabarti SS et al. Ceramide and Sphingosine-1-Phosphate in Cell Death Pathways : Relevance to the Pathogenesis of Alzheimer's Disease. 2016 Curr Alzheimer Res pmid:27335046
Tsai HC and Han MH Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation. 2016 Drugs pmid:27318702
Pyne S et al. Sphingosine 1-phosphate and sphingosine kinases in health and disease: Recent advances. 2016 Prog. Lipid Res. pmid:26970273
Aoki M et al. Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic Potential. 2016 Mediators Inflamm. pmid:26966342
Brinck JW et al. Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell Protection. 2016 Arterioscler. Thromb. Vasc. Biol. pmid:26966278
Chawla S et al. S1P prophylaxis mitigates acute hypobaric hypoxia-induced molecular, biochemical, and metabolic disturbances: A preclinical report. 2016 IUBMB Life pmid:26959531
Chapurlat RD and Confavreux CB Novel biological markers of bone: from bone metabolism to bone physiology. 2016 Rheumatology (Oxford) pmid:26790456
Zhang Y et al. Ceramide Production Mediates Aldosterone-Induced Human Umbilical Vein Endothelial Cell (HUVEC) Damages. 2016 PLoS ONE pmid:26788916
Dillmann C et al. S1PR4 Signaling Attenuates ILT 7 Internalization To Limit IFN-α Production by Human Plasmacytoid Dendritic Cells. 2016 J. Immunol. pmid:26783340
Ghasemi R et al. Integrated sphingosine-1 phosphate signaling in the central nervous system: From physiological equilibrium to pathological damage. 2016 Pharmacol. Res. pmid:26772814
Morel S et al. Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43. 2016 Cardiovasc. Res. pmid:26762268
Realini N et al. Acid Ceramidase in Melanoma: EXPRESSION, LOCALIZATION, AND EFFECTS OF PHARMACOLOGICAL INHIBITION. 2016 J. Biol. Chem. pmid:26553872
Campos LS et al. Filamin A Expression Negatively Regulates Sphingosine-1-Phosphate-Induced NF-κB Activation in Melanoma Cells by Inhibition of Akt Signaling. 2016 Mol. Cell. Biol. pmid:26552704
Liu X et al. Transforming growth factor-β-sphingosine kinase 1/S1P signaling upregulates microRNA-21 to promote fibrosis in renal tubular epithelial cells. 2016 Exp. Biol. Med. (Maywood) pmid:26376826
Filipenko I et al. Upregulation of the S1P3 receptor in metastatic breast cancer cells increases migration and invasion by induction of PGE2 and EP2/EP4 activation. 2016 Biochim. Biophys. Acta pmid:27616330
Japtok L et al. Sphingosine 1-phosphate counteracts insulin signaling in pancreatic β-cells via the sphingosine 1-phosphate receptor subtype 2. 2015 FASEB J. pmid:25911610
Stone ML et al. Sphingosine-1-phosphate receptor 1 agonism attenuates lung ischemia-reperfusion injury. 2015 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:25910934
Farnoud AM et al. The Granuloma Response Controlling Cryptococcosis in Mice Depends on the Sphingosine Kinase 1-Sphingosine 1-Phosphate Pathway. 2015 Infect. Immun. pmid:25895971
Chimen M et al. Homeostatic regulation of T cell trafficking by a B cell-derived peptide is impaired in autoimmune and chronic inflammatory disease. 2015 Nat. Med. pmid:25894827
Urtz N et al. Sphingosine 1-Phosphate Produced by Sphingosine Kinase 2 Intrinsically Controls Platelet Aggregation In Vitro and In Vivo. 2015 Circ. Res. pmid:26129975
Desai P et al. Dyslipidemia regulates thrombospondin-1-induced vascular smooth muscle cell chemotaxis. 2015 Mol. Cell. Biochem. pmid:26350564
Moolenaar WH Introduction to the ECR special issue on lysophospholipids in biology. 2015 Exp. Cell Res. pmid:25746723
Brulhart-Meynet MC et al. Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injury. 2015 PLoS ONE pmid:25781943
Nojima H et al. Sphingolipids in liver injury, repair and regeneration. 2015 Biol. Chem. pmid:25781682
Newton J et al. Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy. 2015 Exp. Cell Res. pmid:25770011
Muñoz-Sáez E et al. Neuroprotective role of sphingosine-1-phosphate in L-BMAA treated neuroblastoma cells (SH-SY5Y). 2015 Neurosci. Lett. pmid:25769802
Kang H et al. The Therapeutic Effects of Human Mesenchymal Stem Cells Primed with Sphingosine-1 Phosphate on Pulmonary Artery Hypertension. 2015 Stem Cells Dev. pmid:25761906
Carrera I et al. A comparative evaluation of a novel vaccine in APP/PS1 mouse models of Alzheimer's disease. 2015 Biomed Res Int pmid:25759822
Ueda N Ceramide-induced apoptosis in renal tubular cells: a role of mitochondria and sphingosine-1-phoshate. 2015 Int J Mol Sci pmid:25751724
Zhao S and Li J Sphingosine-1-phosphate induces the migration of thyroid follicular carcinoma cells through the microRNA-17/PTK6/ERK1/2 pathway. 2015 PLoS ONE pmid:25748447
Lin CC et al. Sphingosine-1-phosphate mediates ICAM-1-dependent monocyte adhesion through p38 MAPK and p42/p44 MAPK-dependent Akt activation. 2015 PLoS ONE pmid:25734900
O'Sullivan C and Dev KK Galactosylsphingosine (psychosine)-induced demyelination is attenuated by sphingosine 1-phosphate signalling. 2015 J. Cell. Sci. pmid:26359302
Borup A et al. Apolipoprotein M in lipid metabolism and cardiometabolic diseases. 2015 Curr. Opin. Lipidol. pmid:25551802
Montecucco F et al. Impact of systemic inflammation and autoimmune diseases on apoA-I and HDL plasma levels and functions. 2015 Handb Exp Pharmacol pmid:25522998
Nofer JR Signal transduction by HDL: agonists, receptors, and signaling cascades. 2015 Handb Exp Pharmacol pmid:25522990
Baranowski M et al. Exercise increases sphingoid base-1-phosphate levels in human blood and skeletal muscle in a time- and intensity-dependent manner. 2015 Eur. J. Appl. Physiol. pmid:25519954
Oskeritzian CA et al. The sphingosine-1-phosphate/sphingosine-1-phosphate receptor 2 axis regulates early airway T-cell infiltration in murine mast cell-dependent acute allergic responses. 2015 J. Allergy Clin. Immunol. pmid:25512083
Kurano M et al. LDL receptor and ApoE are involved in the clearance of ApoM-associated sphingosine 1-phosphate. 2015 J. Biol. Chem. pmid:25505264
Konstantinou D et al. Growth factors mediated differentiation of mesenchymal stem cells to cardiac polymicrotissue using hanging drop and bioreactor. 2015 Cell Biol. Int. pmid:25492631
Pyne NJ and Kolesnick RN The life and work of Dr. Robert Bittman (1942-2014). 2015 Biol. Chem. pmid:25473803
Benesch MG et al. Regulation of autotaxin expression and secretion by lysophosphatidate and sphingosine 1-phosphate. 2015 J. Lipid Res. pmid:25896349
Klocke S et al. Slow-freezing versus vitrification for human ovarian tissue cryopreservation. 2015 Arch. Gynecol. Obstet. pmid:25115279
Wysoczynski M et al. Identification of heme oxygenase 1 (HO-1) as a novel negative regulator of mobilization of hematopoietic stem/progenitor cells. 2015 Stem Cell Rev pmid:25086571
Burow P et al. Activation of ATP secretion via volume-regulated anion channels by sphingosine-1-phosphate in RAW macrophages. 2015 Pflugers Arch. pmid:24965069
Pan HY et al. Sphingosine-1-phosphate mediates AKT/ERK maintenance of dental pulp homoeostasis. 2015 Int Endod J pmid:24931601
Siow D et al. Regulation of de novo sphingolipid biosynthesis by the ORMDL proteins and sphingosine kinase-1. 2015 Adv Biol Regul pmid:25319495
Sano N et al. New drug delivery system for liver sinusoidal endothelial cells for ischemia-reperfusion injury. 2015 World J. Gastroenterol. pmid:26668502
Liu R et al. Taurocholate Induces Cyclooxygenase-2 Expression via the Sphingosine 1-phosphate Receptor 2 in a Human Cholangiocarcinoma Cell Line. 2015 J. Biol. Chem. pmid:26518876
Wang R et al. Exosome Adherence and Internalization by Hepatic Stellate Cells Triggers Sphingosine 1-Phosphate-dependent Migration. 2015 J. Biol. Chem. pmid:26534962
Fujii S [Atherosclerosis, Chronic Inflammation, and Thrombosis: In Search of the Missing Link in Laboratory Medicine]. 2015 Rinsho Byori pmid:26524900
Jones EE et al. Tissue biomarkers of drug efficacy: case studies using a MALDI-MSI workflow. 2015 Bioanalysis pmid:26505686
Ramos-Perez WD et al. A map of the distribution of sphingosine 1-phosphate in the spleen. 2015 Nat. Immunol. pmid:26502404
Winkler MS et al. Decreased serum concentrations of sphingosine-1-phosphate in sepsis. 2015 Crit Care pmid:26498205
Matula K et al. Regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer. 2015 BMC Cancer pmid:26493335
Barnawi J et al. Potential Link between the Sphingosine-1-Phosphate (S1P) System and Defective Alveolar Macrophage Phagocytic Function in Chronic Obstructive Pulmonary Disease (COPD). 2015 PLoS ONE pmid:26485657
Moruno Manchon JF et al. Cytoplasmic sphingosine-1-phosphate pathway modulates neuronal autophagy. 2015 Sci Rep pmid:26477494
Deng Z et al. Enterobacteria-secreted particles induce production of exosome-like S1P-containing particles by intestinal epithelium to drive Th17-mediated tumorigenesis. 2015 Nat Commun pmid:25907800
Wang K et al. Alkaline Ceramidase 3 Deficiency Results in Purkinje Cell Degeneration and Cerebellar Ataxia Due to Dyshomeostasis of Sphingolipids in the Brain. 2015 PLoS Genet. pmid:26474409
Kihara Y et al. Lysophospholipid receptors in drug discovery. 2015 Exp. Cell Res. pmid:25499971
Kim ES et al. A natural piper-amide-like compound NED-135 exhibits a potent inhibitory effect on the invasive breast cancer cells. 2015 Chem. Biol. Interact. pmid:25980589
Boczkowska-Radziwon B et al. Ozonation of human blood increases sphingosine-1-phosphate in plasma. 2015 J. Physiol. Pharmacol. pmid:25903957
Cheng Y et al. Actin polymerization-enhancing drugs promote ovarian follicle growth mediated by the Hippo signaling effector YAP. 2015 FASEB J. pmid:25690654
Choi S et al. A genetic variant of cortactin linked to acute lung injury impairs lamellipodia dynamics and endothelial wound healing. 2015 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:26361873
Le Bihan O et al. Visualization of adherent cell monolayers by cryo-electron microscopy: A snapshot of endothelial adherens junctions. 2015 J. Struct. Biol. pmid:26470813
Flávia Nardy A et al. Modulation of Intrathymic Sphingosine-1-Phosphate Levels Promotes Escape of Immature Thymocytes to the Periphery with a Potential Proinflammatory Role in Chagas Disease. 2015 Biomed Res Int pmid:26347020
Dai L et al. Ceramides promote apoptosis for virus-infected lymphoma cells through induction of ceramide synthases and viral lytic gene expression. 2015 Oncotarget pmid:26327294
Simón MV et al. Sphingosine-1-Phosphate Is a Crucial Signal for Migration of Retina Müller Glial Cells. 2015 Invest. Ophthalmol. Vis. Sci. pmid:26325420
Yang L et al. Sphingosine 1-Phosphate Receptor 2 and 3 Mediate Bone Marrow-Derived Monocyte/Macrophage Motility in Cholestatic Liver Injury in Mice. 2015 Sci Rep pmid:26324256
Brünnert D et al. Sphingosine 1-phosphate regulates IL-8 expression and secretion via S1PR1 and S1PR2 receptors-mediated signaling in extravillous trophoblast derived HTR-8/SVneo cells. 2015 Placenta pmid:26321412
Zhao YD et al. A Biochemical Approach to Understand the Pathogenesis of Advanced Pulmonary Arterial Hypertension: Metabolomic Profiles of Arginine, Sphingosine-1-Phosphate, and Heme of Human Lung. 2015 PLoS ONE pmid:26317340
Hsu CK et al. Mevastatin ameliorates sphingosine 1-phosphate-induced COX-2/PGE2-dependent cell migration via FoxO1 and CREB phosphorylation and translocation. 2015 Br. J. Pharmacol. pmid:26359950
Michels M et al. Decreased plasma levels of the endothelial protective sphingosine-1-phosphate are associated with dengue-induced plasma leakage. 2015 J. Infect. pmid:26183296
Checa A et al. Circulating levels of sphingosine-1-phosphate are elevated in severe, but not mild psoriasis and are unresponsive to anti-TNF-α treatment. 2015 Sci Rep pmid:26174087
Schaffert SA et al. mir-181a-1/b-1 Modulates Tolerance through Opposing Activities in Selection and Peripheral T Cell Function. 2015 J. Immunol. pmid:26163591
Gao Y et al. Sphingosine kinase 1 as an anticancer therapeutic target. 2015 Drug Des Devel Ther pmid:26150697
Denimal D et al. Significant abnormalities of the HDL phosphosphingolipidome in type 1 diabetes despite normal HDL cholesterol concentration. 2015 Atherosclerosis pmid:26142685
Yagi K et al. Therapeutically Targeting Tumor Necrosis Factor-α/Sphingosine-1-Phosphate Signaling Corrects Myogenic Reactivity in Subarachnoid Hemorrhage. 2015 Stroke pmid:26138121
Nakagawa Y and Chiba K Diversity and plasticity of microglial cells in psychiatric and neurological disorders. 2015 Pharmacol. Ther. pmid:26129625
Jeong SK et al. Sphingosine kinase 1 activation enhances epidermal innate immunity through sphingosine-1-phosphate stimulation of cathelicidin production. 2015 J. Dermatol. Sci. pmid:26113114
Marycz K et al. The effect of the bioactive sphingolipids S1P and C1P on multipotent stromal cells--new opportunities in regenerative medicine. 2015 Cell. Mol. Biol. Lett. pmid:26110483
El-Najjar N et al. Increased Levels of Sphingosylphosphorylcholine (SPC) in Plasma of Metabolic Syndrome Patients. 2015 PLoS ONE pmid:26466367
Hyder CL et al. Sphingolipids inhibit vimentin-dependent cell migration. 2015 J. Cell. Sci. pmid:25908861
Tian H and Yu Z Resveratrol induces apoptosis of leukemia cell line K562 by modulation of sphingosine kinase-1 pathway. 2015 Int J Clin Exp Pathol pmid:26045781
Rosenberg AJ et al. A practical process for the preparation of [(32)P]S1P and binding assay for S1P receptor ligands. 2015 Appl Radiat Isot pmid:25931137
Trayssac M et al. Role of Sphingosine-1-Phosphate in Transplant Vasculopathy Evoked by Anti-HLA Antibody. 2015 Am. J. Transplant. pmid:25930666
Pulkoski-Gross MJ et al. Sphingosine-1-phosphate metabolism: A structural perspective. 2015 Crit. Rev. Biochem. Mol. Biol. pmid:25923252
Ader I et al. Neutralizing S1P inhibits intratumoral hypoxia, induces vascular remodelling and sensitizes to chemotherapy in prostate cancer. 2015 Oncotarget pmid:25915662